Hormone receptor positive, HER2 negative metastatic breast cancer: Future treatment landscape-Reference-Cited by-同舟云学术

Hormone receptor positive, HER2 negative metastatic breast cancer: Future treatment landscape

Published:2016-03 Issue: Volume:12 Page:19-31
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

REDFERN Andrew¹,BURSLEM Katie²,WOODWARD Natasha³,BEITH Jane⁴,MCCARTHY Nicole⁵,DE BOER Richard⁶,BELL Richard⁷

Affiliation:

1. Fiona Stanley Hospital; Perth Western Australia Australia

2. WriteSource Medical Pty Ltd; Sydney New South Wales Australia

3. Mater Health Services/Mater Research Institute; South Brisbane Queensland Australia

4. Chris O'Brien Lifehouse; Camperdown New South Wales Australia

5. Wesley Medical Centre, Auchenflower, and University of Queensland; Queensland Australia

6. Royal Melbourne Hospital; Parkville Victoria Australia

7. Deakin University; Warun Ponds Victoria Australia

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12492/fullpdf

Reference56 articles.

1. Treatment considerations for the management of patients with hormone receptor-positive metastatic breast cancer;Visovsky;J Adv Pract Oncol,2014

2. Optimal management of hormone receptor positive metastatic breast cancer in 2016;Reinert;Ther Adv Med Oncol,2015

3. Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer;Bodmer;Eur J Cancer,2011

4. Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis;Yardley;Adv Ther,2013

5. U.S. Department of Health and Human Services FDA Guidance for Industry: Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics 2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The nebula of chronicity: dealing with metastatic breast cancer in the UK;Anthropology & Medicine;2022-01-02

2. Optimizing Quality of Life in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: Treatment Options and Considerations;Oncology;2017